公开(公告)号：EP2379090A1

公开(公告)日：2011-10-26

申请号：EP09838945.5

申请日：2009-12-18

申请人： Bomac Research Limited

发明人： LEECH, Wayne Frederick

IPC分类号： A61K35/56 ,  A61K31/403 ,  A61P19/02 ,  A61K31/192 ,  A61K31/404 ,  A61P19/04 ,  A61K31/196 ,  A61K31/415 ,  A61K31/365 ,  A61K31/5415

CPC分类号： A61K31/415 ,  A61K31/192 ,  A61K31/196 ,  A61K31/365 ,  A61K31/403 ,  A61K31/404 ,  A61K31/5415 ,  A61K35/618 ,  A61K2300/00

摘要： The present invention relates to a composition for an animal within a particular weight range including at least one non-steroidal anti-inflammatory drug (NSAID) compound and at least one mussel extract characterised in that the therapeutic dose of NSAID compound in the composition is substantially less than the usual therapeutic dose.

公开(公告)号：EP1408999B1

公开(公告)日：2008-03-12

申请号：EP00950109.9

申请日：2000-07-21

申请人： Bomac Research Limited

发明人： HASHMI, Syed, Ziauddin ,  LEECH, Wayne, Frederick ,  MCLAREN, Donald, George ,  MCSPORRAN, Keith, David

IPC分类号： A61K35/56 ,  A61K36/15 ,  A61P29/00

CPC分类号： A61K35/60 ,  A61K35/618 ,  A61K36/15 ,  A61K2300/00

摘要： Compositions for primarily addressing degenerative complaints, in particular joint related conditions such as arthritis and rheumatism, in which there may also be associated inflammation, are provided. Other potential uses are also discussed, as well as prophylactic and curative applications. Preferred embodiments incorporate green-lip mussel products (particularly GLME) with shark cartilage or chondroitin compounds, and plant and bark based antioxidants are employed in a number of embodiments.

公开(公告)号：EP2376113A1

公开(公告)日：2011-10-19

申请号：EP09839765.6

申请日：2009-12-15

申请人： Bomac Research Limited

发明人： LEECH, Wayne, Frederick

IPC分类号： A61K39/08 ,  A61K31/429 ,  A61P31/04 ,  A61P33/10

CPC分类号： A61K39/08 ,  A61K9/0019 ,  A61K31/429 ,  A61K45/06 ,  A61K2039/545 ,  A61K2039/552 ,  A61K2300/00

摘要： A composition and dosage regime including a vaccine and levamisole for the treatment of clostridial diseases and helminthiasis. New methods of administration relating to particular dosage regimes of such a composition are also claimed.

摘要翻译： 包含疫苗和左旋咪唑的组合物和剂量方案用于治疗梭菌病和蠕虫病。 要求保护涉及这种组合物的特定剂量方案的新的施用方法。

公开(公告)号：EP2361053A1

公开(公告)日：2011-08-31

申请号：EP09829371.5

申请日：2009-06-29

申请人： Bomac Research Limited

发明人： LEECH, Wayne, Frederick ,  POMROY, William, Ernest

IPC分类号： A61D7/00 ,  A61K31/429 ,  A61P33/00 ,  A61K9/22 ,  A61K31/7048 ,  A61K9/52 ,  A61K33/44

CPC分类号： A61K31/429 ,  A61K9/0068 ,  A61K31/00 ,  A61K31/7048 ,  A61K2300/00

摘要： A bolus for administration of a substance to an animal, the bolus including An external coating, and A core inside the external coating wherein the core is formed from a plurality of dosage media, wherein each dosage media contains a substance, the bolus characterised in that the dosage media are ordered within the bolus such that the amount of substance released by each dosage media is progressively more than the amount of substance released by the previous dosage media.

公开(公告)号：EP2182884A1

公开(公告)日：2010-05-12

申请号：EP08827274.5

申请日：2008-08-14

申请人： Bomac Research Limited

发明人： LEECH, Wayne, Frederick

IPC分类号： A61D7/00 ,  B65D30/22 ,  B65D81/32

CPC分类号： A61D7/00 ,  A61J1/10 ,  A61J1/2027 ,  A61J1/2093 ,  B65D75/5883 ,  B65D81/3261

摘要： The present invention relates to a treatment apparatus in the form of a bag which includes a first compartment containing at least one treatment substance, a second compartment containing at least one treatment substance, at least one openable seal between the first and second compartments, characterised in that at least one treatment substance in the first compartment is incompatible over time with at least one treatment substance in the second compartment.

公开(公告)号：EP2361055A1

公开(公告)日：2011-08-31

申请号：EP09829372.3

申请日：2009-08-21

申请人： Bomac Research Limited

发明人： LEECH, Wayne, Frederick ,  POMROY, William Ernest

IPC分类号： A61F2/00 ,  A61J3/00 ,  A61J3/08 ,  A61M31/00 ,  A61K9/02

CPC分类号： A61K31/429 ,  A61K9/0068 ,  A61K31/00 ,  A61K31/7048 ,  A61K2300/00

摘要： A bolus for administration of a substance to an animal, the bolus including An external coating, and A core inside the external coating wherein the core is formed from a plurality of dosage media, wherein each dosage media contains a substance, the bolus characterised in that the dosage media are ordered within the bolus such that the amount of substance released by each dosage media is progressively more than the amount of substance released by the previous dosage media.

公开(公告)号：EP2124938A1

公开(公告)日：2009-12-02

申请号：EP08724001.6

申请日：2008-01-22

申请人： Bomac Research Limited

发明人： NANJAN, Karthigeyan ,  AL ALAWI, Fadil ,  CHAMBERS, Paul ,  HILL, Kate

IPC分类号： A61K31/4164 ,  A61P5/14 ,  A61P5/16

CPC分类号： A61K31/4164 ,  A61K9/0017 ,  A61K47/10 ,  A61K47/12 ,  A61K47/22 ,  A61K47/34

摘要： The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.